GlassScriptPhysician profile
Pranav V Doshi
NPI 1013170612
$17,752.69
in general payments reported to CMS, 2019-2025
36 companies · $2,659 in 2025
The $2,659 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,372 · 2020: $8,125 · 2021: $1,396 · 2022: $748 · 2023: $1,579 · 2024: $873 · 2025: $2,659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,808 · Travel and Lodging: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,808.02 |
| Travel and Lodging | $1,303.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $6,642.41 | 2019-2021 | |
| Edwards Lifesciences Corporation | $2,996.64 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $2,877.17 | 2019-2025 | Versacross Access Solution, General - Tachy, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $2,532.99 | 2019-2025 | Gallant, Portico, Xience Skypoint |
| Cardiovascular Systems INC. | $621.28 | 2019-2022 | |
| Philips North America LLC | $579.33 | 2019-2025 | Labosys |
| Novartis Pharmaceuticals Corporation | $142.01 | 2019-2025 | |
| Amgen INC. | $134.28 | 2021-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $131.55 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $117.21 | 2020-2023 | Xarelto |
| Novo Nordisk INC | $91.91 | 2024 | Wegovy |
| Heartflow, INC. | $84.29 | 2023 | Ffrct |
| Abiomed | $79.98 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $72.64 | 2019-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $72.43 | 2019-2024 | Camzyos |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $69.91 | 2019-2024 | Zilver Ptx |
| Medtronic Vascular, INC. | $65.20 | 2019 | |
| Pfizer INC. | $55.64 | 2019-2022 | |
| Endologix LLC | $43.72 | 2019 | |
| Merck Sharp & Dohme LLC | $38.10 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $35.64 | 2022-2023 | Uptravi, Opsumit |
| Lantheus Medical Imaging, INC. | $31.97 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $27.41 | 2019 | |
| Angiodynamics, INC. | $22.67 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.77 | 2019-2024 | Lifevest |
| Medtronic, INC. | $18.10 | 2021 | |
| Scpharmaceuticals INC. | $17.10 | 2024 | |
| Baxter Healthcare | $16.69 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Impulse Dynamics (USA) INC. | $15.87 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.77 | 2019 | |
| Bard Peripheral Vascular, INC. | $15.73 | 2021 | |
| Astellas Pharma US INC | $15.39 | 2023 | Lexiscan |
| Inari Medical, INC. | $15.09 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.60 | 2021 | |
| Chiesi USA, INC. | $12.89 | 2021 | |
| Advanced Oxygen Therapy INC. | $8.31 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pranav Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.